Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1996 1
1997 1
1998 1
1999 2
2000 2
2001 1
2002 1
2003 5
2004 6
2005 2
2006 8
2007 10
2008 8
2009 7
2010 6
2011 6
2012 7
2013 4
2014 6
2015 4
2016 9
2017 5
2018 9
2019 10
2020 17
2021 11
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Pretomanid for tuberculosis: a systematic review.
Gils T, Lynen L, de Jong BC, Van Deun A, Decroo T. Gils T, et al. Among authors: van deun a. Clin Microbiol Infect. 2022 Jan;28(1):31-42. doi: 10.1016/j.cmi.2021.08.007. Epub 2021 Aug 14. Clin Microbiol Infect. 2022. PMID: 34400340 Free article. Review.
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Goodall RL, Meredith SK, Nunn AJ, Bayissa A, Bhatnagar AK, Bronson G, Chiang CY, Conradie F, Gurumurthy M, Kirenga B, Kiria N, Meressa D, Moodliar R, Narendran G, Ngubane N, Rassool M, Sanders K, Solanki R, Squire SB, Torrea G, Tsogt B, Tudor E, Van Deun A, Rusen ID; STREAM study collaborators. Goodall RL, et al. Among authors: van deun a. Lancet. 2022 Nov 26;400(10366):1858-1868. doi: 10.1016/S0140-6736(22)02078-5. Epub 2022 Nov 8. Lancet. 2022. PMID: 36368336 Free PMC article. Clinical Trial.
Multidrug-resistant tuberculosis.
Chiang CY, Van Deun A, Trébucq A, Piubello A, Schwoebel V, Rieder HL. Chiang CY, et al. Among authors: van deun a. Lancet. 2019 Jul 27;394(10195):299. doi: 10.1016/S0140-6736(19)30046-7. Lancet. 2019. PMID: 31354138 No abstract available.
Implications of bedaquiline-resistant tuberculosis.
Decroo T, van Deun A. Decroo T, et al. Among authors: van deun a. Lancet Infect Dis. 2022 Feb;22(2):166-167. doi: 10.1016/S1473-3099(22)00008-1. Lancet Infect Dis. 2022. PMID: 35092789 No abstract available.
How Second-Line Injectable Drugs Work.
Van Deun A, Decroo T. Van Deun A, et al. Clin Infect Dis. 2021 Jun 15;72(12):e1167-e1168. doi: 10.1093/cid/ciaa1874. Clin Infect Dis. 2021. PMID: 33341871 No abstract available.
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis.
Nunn AJ, Phillips PPJ, Meredith SK, Chiang CY, Conradie F, Dalai D, van Deun A, Dat PT, Lan N, Master I, Mebrahtu T, Meressa D, Moodliar R, Ngubane N, Sanders K, Squire SB, Torrea G, Tsogt B, Rusen ID; STREAM Study Collaborators. Nunn AJ, et al. Among authors: van deun a. N Engl J Med. 2019 Mar 28;380(13):1201-1213. doi: 10.1056/NEJMoa1811867. Epub 2019 Mar 13. N Engl J Med. 2019. PMID: 30865791 Free article. Clinical Trial.
Recurrence in tuberculosis: relapse or reinfection?
Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P. Lambert ML, et al. Among authors: van deun a. Lancet Infect Dis. 2003 May;3(5):282-7. doi: 10.1016/s1473-3099(03)00607-8. Lancet Infect Dis. 2003. PMID: 12726976 Review.
156 results